that can mimic early symptoms of TB; 2,5,6 the nature of pulmonary TB (PTB) disease in HIV-infected people, which often renders sputum smear microscopy (the most commonly available diagnostic tool in resourcelimited settings) negative; 7 and the fear of use of chest radiography (CXR) in pregnancy due to concerns regarding radiation-induced teratogenicity. 5 Symptom screening is recommended to identify TB suspects in HIV-infected populations, 8 including pregnant women, 9 but it has not been evaluated in HIVi nfected pregnant women. The study populations of the two most recent published studies, Cain et al. and Corbett et al., were composed of HIV-infected adult patients but were not stratifi ed with regard to pregnancy status. 10, 11 Similarly, in a meta-analysis of observational studies there was no stratifi cation based on pregnancy status. 8 As such these results may not be applicable to the HIV-infected pregnant population. In a PMTCT program in western Kenya, access to clinical laboratory services and CXR allowed for in-depth investigations into the role of symptom screening in HIV-infected pregnant women.
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The aim of this study was to determine the diagnostic usefulness of symptom screening for TB in detecting active PTB among HIV-infected pregnant women in two PMTCT clinics in western Kenya. This was a descriptive analysis of women who were positive or negative on symptom screening to compare demographics, sputum results, CXR results and TB diagnosis.
METHODS

Study design
This was a cross-sectional analysis of data.
Setting
The study was carried out in two Government of K enya PMTCT clinics, Eldoret and Busia in western Kenya, which are supported by the Academic Model Providing Access to Healthcare (AMPATH) partnership. [12] [13] [14] These two sites were chosen because they represented the busiest PMTCT programs in AMPATH (on average 30 patients each per month), both had access to a quality-controlled TB laboratory, were capable of smear microscopy and rapid culture (Mycobacteria Growth Indicator Tube), and both sites had functional CXR, with appropriate shielding for pregnant women. This study took place between 1 October 2009 and 28 February 2010.
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D
espite the fact that tuberculosis (TB) is the most common opportunistic infection in persons living with HIV/AIDS (human immunodefi ciency virus/ acquired immune-defi ciency syndrome), as well as a signifi cant cause of maternal mortality and morbidity in this group, screening is not routinely done in PMTCT (prevention of mother-to-child transmission) settings. [1] [2] [3] [4] This omission is likely related to clinicianperceived urgency in initiating antiretroviral therapy (ART), coupled with the challenges inherent in the screening process for active TB in HIV-infected pregnant women.
The challenges of PMTCT ART initiation have been well addressed, with the establishment of programs throughout the world. However, the challenges related to screening for TB remain unaddressed in any systematic approach. This population represents its own challenges: the non-specifi c nature of early pregnancy symptoms (such as frequency of malaise and fatigue) 
Participants and sample
Study participants were newly enrolled (i.e., ART naïve), HIV-infected pregnant women aged 15-49 years who attended the two selected PMTCT clinics. Those already on TB treatment at the time of enrolment or with a past history of isoniazid preventive therapy (IPT) were excluded. Convenience sampling was used at weekly clinic visits over the 5-month study period, enrolling all consecutive eligible women until the sample size was obtained (n = 187). Sample size was calculated using 12.5% as the expected prevalence of TB in HIV-infected pregnant women, with 80% power, yielding a sample of 187. 15 
Study procedure
All study participants were interviewed by the primary researcher regarding demographic variables and current symptoms: cough for >2 weeks, fever, night sweats, weight loss or failure to gain weight. The standardized symptom screen questionnaire used was developed and standardized in Kenya at multiple sites in the late 1990s, and has been used extensively in an intensifi ed case fi nding program for TB in western Kenya. Although not specifi cally standardized for studies in HIV-infected individuals, its broad use in our region has provided staff with a degree of familiarity in its use.
Patients with a positive symptom screen that included the presence of cough were asked to supply two sputum specimens (one spot and one morning) to be sent for smear microscopy and TB culture. All smear microscopy and TB cultures were sent to the regional reference laboratory, which is ISO (International Organization for Standardization) 15 189 certifi ed as adhering to international harmonization standards for good laboratory practice. Smear was performed on unconcentrated sputum. Specimens were pooled for culture. Women post 14 weeks gestation underwent shielded CXR with their permission. All CXRs were read by a single consultant radiologist.
Outcome variables
TB diagnosis was defi ned as confi rmed if either smear or culture was positive, and presumptive if the CXR was interpreted as suggestive of TB (cavitary, miliary pattern or infi ltrate). All patients diagnosed with either confi rmed or presumptive TB disease were referred back to their care providers for management, according to the hospital protocols.
Ethics
The study had the ethical approval of the
RESULTS
A total of 187 HIV-infected pregnant women attending our PMTCT clinics were included in the study, of whom 38 (20%) were symptom screen-positive. Their characteristics are summarized in Table 1 . The mean age of the participants was 27 years. There were no significant differences in age, educational level, employment status, parity, CD4 count at enrolment or gestational age between patients with and without TB symptoms. Patients' HIV was not advanced, as shown by a mean CD4 count of >450 cells/μl in both groups.
Results of the diagnostic screening are shown in the Figure. Of the 38 patients with a positive symptom screen, 21 had had a cough for >2 weeks. Sputum samples were collected from those patients: all were TB smear-and culture-negative. CXR was offered to all women who were at >14 weeks' gestation. In the symptomatic group, 26 CXRs were performed, of which three were suggestive of TB (1 miliary, 1 infi ltrative, 1 cavitary). Of 149 women with a negative symptom screen, 100 consented; of these, seven had a CXR suggestive of TB (2 miliary 
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In all 10 patients with CXRs suggestive of TB (three with positive symptom screen and seven without), there was no correlation between symptoms and r adiographic patterns, age and CD4 counts ( Table 2 ). All 10 patients were evaluated by their care provider and initiated on TB treatment according to both national and AMPATH guidelines.
DISCUSSION
This study examined the utility of symptom screening in HIVi nfected pregnant women combined with sputum TB smear, TB culture and CXR. The symptom screening tool failed to detect TB in this population. Of 26 symptomatic patients who underwent CXR, only three had abnormal CXRs consistent with TB and none had positive smears, while seven of 100 asymptomatic patients who underwent CXR were treated for TB. This is a disappointing fi nding, as it was hoped that a questionnaire screening tool might assist in guiding targeting specifi c subpopulations for further TB screening in pregnancy. Reliance on TB symptom screening alone in HIV-infected pregnant women in our setting was thus not helpful in deciding who should receive the next level of TB screening (in our setting a CXR).
Our symptom screen fi ndings are similar to those in a study of 370 HIV-infected pregnant women in a PMTCT clinic, Soweto, South Africa, also with high CD4 counts. That study discovered a similar rate of symptom screen-positive HIV-infected pregnant women; 120 (32%) were symptomatic by screen, and eight were diagnosed with TB by culture. 4 That study did not perform CXRs among symptomatic or asymptomatic women.
CXR did discover abnormalities in this patient population, in both symptomatic and asymptomatic individuals, and thus may be an important tool in this group. A limitation of this suggestion, however, is that these women could only be classifi ed as presumptive TB, as no symptomatic women were confi rmed by TB culture, and asymptomatic women did not undergo culture. This meant that sensitivity, specifi city and predictive values could not be calculated.
This study suggests that reliance solely on symptom screening to diagnose TB in HIV-infected pregnant women in settings such as ours is insuffi cient for either making or ruling out a diagnosis of TB. The evidence from this study is that symptom screening in our setting needs to be coupled with CXR to access the need for drug treatment for TB disease or IPT. Further studies of both HIVinfected and non-infected pregnant populations with different TB burdens are required. A diagnosis of TB has outcome implications for both mother and child. The barriers intrinsic to studies in this vulnerable patient population should be addressed to design scientifi cally evaluated guidelines for their care.
A strength of this study is that symptom screening was applied in a standardized manner, under routine program conditions, that would be applicable to other PMTCT care programs. This study also had access to a quality-controlled TB laboratory, functional radiology units and a consultant radiologist. Finally, the observational study adhered to STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. 16 In conclusion, this study did not support the utility of isolated symptom screening in the identifi cation of TB disease in our PMTCT setting. CXR was useful in the identifi cation of TB suspects in both symptomatic and asymptomatic women. Given the profound risks of TB to the HIV-infected pregnant woman and her infant, further well-designed studies targeted at best TB screening practices in this specifi c population are needed. 
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